MenT nucleotidyltransferase toxins extend tRNA acceptor stems and can be inhibited by asymmetrical antitoxin binding.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 08 2023
Historique:
received: 28 02 2023
accepted: 20 07 2023
medline: 21 8 2023
pubmed: 18 8 2023
entrez: 17 8 2023
Statut: epublish

Résumé

Mycobacterium tuberculosis, the bacterium responsible for human tuberculosis, has a genome encoding a remarkably high number of toxin-antitoxin systems of largely unknown function. We have recently shown that the M. tuberculosis genome encodes four of a widespread, MenAT family of nucleotidyltransferase toxin-antitoxin systems. In this study we characterize MenAT1, using tRNA sequencing to demonstrate MenT1 tRNA modification activity. MenT1 activity is blocked by MenA1, a short protein antitoxin unrelated to the MenA3 kinase. X-ray crystallographic analysis shows blockage of the conserved MenT fold by asymmetric binding of MenA1 across two MenT1 protomers, forming a heterotrimeric toxin-antitoxin complex. Finally, we also demonstrate tRNA modification by toxin MenT4, indicating conserved activity across the MenT family. Our study highlights variation in tRNA target preferences by MenT toxins, selective use of nucleotide substrates, and diverse modes of MenA antitoxin activity.

Identifiants

pubmed: 37591829
doi: 10.1038/s41467-023-40264-3
pii: 10.1038/s41467-023-40264-3
pmc: PMC10435456
doi:

Substances chimiques

Antitoxins 0
Nucleotidyltransferases EC 2.7.7.-
Toxins, Biological 0
Nucleotides 0
RNA, Transfer 9014-25-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4644

Informations de copyright

© 2023. The Author(s).

Références

Microbiol Spectr. 2022 Jun 29;10(3):e0058022
pubmed: 35638832
J Infect Dis. 2018 May 5;217(11):1809-1820
pubmed: 29529224
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):478-83
pubmed: 22505268
Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):1002-11
pubmed: 16929101
Nucleic Acids Res. 2002 Jun 15;30(12):e56
pubmed: 12060694
Mol Cell. 2021 Aug 5;81(15):3160-3170.e9
pubmed: 34174184
Nat Microbiol. 2016 Nov 07;2:16202
pubmed: 27819654
J Struct Funct Genomics. 2009 Apr;10(2):137-50
pubmed: 19184528
Nucleic Acids Res. 2018 Sep 6;46(15):7873-7885
pubmed: 29931259
J Bacteriol. 1996 Apr;178(7):2044-50
pubmed: 8606182
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Nucleic Acids Res. 2018 Oct 12;46(18):9253-9263
pubmed: 30219859
Microb Genom. 2020 Nov;6(11):
pubmed: 33074086
Biochim Biophys Acta Gene Regul Mech. 2018 Apr;1861(4):433-441
pubmed: 29374586
Nat Rev Microbiol. 2022 Jun;20(6):335-350
pubmed: 34975154
PLoS One. 2010 Dec 22;5(12):e15667
pubmed: 21203517
Mol Cell. 2019 Mar 21;73(6):1282-1291.e8
pubmed: 30792174
Nat Methods. 2009 Sep;6(9):651-3
pubmed: 19684596
Bioinformatics. 2021 Jun 9;37(9):1312-1314
pubmed: 32956448
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W244-8
pubmed: 15980461
Nat Microbiol. 2017 Jan 09;2:16251
pubmed: 28067906
Structure. 2016 Jun 7;24(6):918-25
pubmed: 27133023
Mol Cell. 2016 Jul 7;63(1):86-96
pubmed: 27264868
Toxins (Basel). 2020 May 16;12(5):
pubmed: 32429486
Proc Natl Acad Sci U S A. 2021 Aug 10;118(32):
pubmed: 34362841
Nucleic Acids Res. 2020 Jul 27;48(13):7532-7544
pubmed: 32501503
Nat Commun. 2015 Jan 22;6:6059
pubmed: 25608501
Trends Microbiol. 2021 May;29(5):388-393
pubmed: 33342606
mBio. 2011 Jun 14;2(3):e00100-11
pubmed: 21673191
Mol Cell. 2020 Jul 16;79(2):280-292.e8
pubmed: 32533919
EMBO Rep. 2004 Feb;5(2):195-200
pubmed: 14726952
Biotechniques. 2020 Feb;68(2):106-110
pubmed: 31937110
PLoS Genet. 2009 Dec;5(12):e1000767
pubmed: 20011113
Cell Rep. 2020 Feb 18;30(7):2106-2114.e5
pubmed: 32075755
Pathogens. 2023 Feb 02;12(2):
pubmed: 36839512
Biochim Biophys Acta. 2013 Jun;1834(6):1155-67
pubmed: 23459128
PLoS Comput Biol. 2019 Apr 25;15(4):e1006946
pubmed: 31022176
Toxins (Basel). 2016 Oct 22;8(10):
pubmed: 27782085
mBio. 2023 Feb 28;14(1):e0346922
pubmed: 36695586
Science. 2014 Jan 10;343(6167):204-8
pubmed: 24408438
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Bioinformatics. 2009 Oct 1;25(19):2607-8
pubmed: 19654119
Mol Cell. 2020 Dec 17;80(6):955-970.e7
pubmed: 33290744
Nucleic Acids Res. 2014 Apr;42(7):4590-605
pubmed: 24465005
Nat Commun. 2022 May 12;13(1):2641
pubmed: 35552387
Commun Biol. 2020 May 7;3(1):216
pubmed: 32382148
Nucleic Acids Res. 2022 Feb 28;50(4):2319-2333
pubmed: 35141752
Nat Chem Biol. 2016 Apr;12(4):208-14
pubmed: 26991085
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
BMC Genomics. 2022 Oct 15;23(1):704
pubmed: 36243697
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Mol Cell. 2013 Nov 7;52(3):447-58
pubmed: 24120662
Nat Commun. 2016 Nov 09;7:13339
pubmed: 27827369
Biochem J. 2020 Jun 26;477(12):2401-2419
pubmed: 32519742
BMC Evol Biol. 2015 Aug 19;15:163
pubmed: 26282127
Toxins (Basel). 2014 Mar 06;6(3):1002-20
pubmed: 24662523
Nucleic Acids Res. 2018 Nov 30;46(21):11639-11655
pubmed: 30329074
Sci Adv. 2020 Jul 29;6(31):eabb6651
pubmed: 32923609
J Bacteriol. 2008 Jul;190(13):4603-9
pubmed: 18441063
Protein Sci. 2018 Jan;27(1):129-134
pubmed: 28875543
Gene. 1995 Sep 22;163(1):41-6
pubmed: 7557476
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Nat Methods. 2007 Feb;4(2):147-52
pubmed: 17179933
Curr Opin Struct Biol. 2011 Feb;21(1):109-18
pubmed: 21315267
Mol Cell. 2018 Jun 7;70(5):768-784
pubmed: 29398446
Mol Microbiol. 2006 Dec;62(5):1447-59
pubmed: 17059567
J Virol. 2014 Mar;88(5):2461-80
pubmed: 24335314
Adv Biosyst. 2020 Mar;4(3):e1900290
pubmed: 32293143
Nucleic Acids Res. 2011 Jan;39(1):202-12
pubmed: 20798174
Mol Biol Evol. 2007 Aug;24(8):1861-71
pubmed: 17545187
RNA. 2018 Mar;24(3):361-370
pubmed: 29180590
Mol Cell. 2021 Jun 3;81(11):2361-2373.e9
pubmed: 33838104
J Mol Biol. 2018 Apr 13;430(8):1141-1156
pubmed: 29518409
Toxins (Basel). 2018 Dec 04;10(12):
pubmed: 30518070
J Bacteriol. 1995 Jul;177(14):4121-30
pubmed: 7608087
mBio. 2019 Jun 18;10(3):
pubmed: 31213559
Science. 2021 Apr 30;372(6541):
pubmed: 33926924
Cell Rep. 2021 Dec 21;37(12):110130
pubmed: 34936863
Microbiology (Reading). 2022 Nov;168(11):
pubmed: 36342835

Auteurs

Xibing Xu (X)

Laboratoire de Microbiologie et Génétique Moléculaires (LMGM), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.

Ben Usher (B)

Department of Biosciences, Durham University, South Road, Durham, DH1 3LE, UK.

Claude Gutierrez (C)

Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.

Roland Barriot (R)

Laboratoire de Microbiologie et Génétique Moléculaires (LMGM), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.

Tom J Arrowsmith (TJ)

Department of Biosciences, Durham University, South Road, Durham, DH1 3LE, UK.

Xue Han (X)

Laboratoire de Microbiologie et Génétique Moléculaires (LMGM), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.

Peter Redder (P)

Laboratoire de Microbiologie et Génétique Moléculaires (LMGM), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.

Olivier Neyrolles (O)

Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France.

Tim R Blower (TR)

Department of Biosciences, Durham University, South Road, Durham, DH1 3LE, UK. timothy.blower@durham.ac.uk.

Pierre Genevaux (P)

Laboratoire de Microbiologie et Génétique Moléculaires (LMGM), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, France. pierre.genevaux@univ-tlse3.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH